Japanese Pharmacology & Therapeutics（JPT）
Vol. 32 Suppl. 2 2004
Opening Remarks
H. Kawasaki
Jpn Pharmacol Ther 2004 32(s2) s95
Association between insun resistance, hepatic iron accumulation, and hepatic steatosis in hepatitis C
Y. Sumida, et al．
Jpn Pharmacol Ther 2004 32(s2) s101
Pathophysiology of nonalcoholic steatohepatitis（NASH）
―Relation to adipocytokine and advanced glycation end products―
H. Hyogo, et al.
Jpn Pharmacol Ther 2004 32(s2) s107
Plasma levels of ADAMTS13 in liver diseases
―With special reference to alcoholic hepatitis―
M. Uemura, et al．
Jpn Pharmacol Ther 2004 32(s2) s111
【Discussion 1～3】
Jpn Pharmacol Ther 2004 32(s2) s115
Cerebral hemodynamics in the patients with fulminant hepatitis
M. Kawakami, et al．
Jpn Pharmacol Ther 2004 32(s2) s117
The influence of radiofrequency ablation on liver parenchymal functionin in patients with hepatocellular carcinoma
―The alteration of serum cytokine and the effect of branched－chain amino acids―
M. Koda, et al．
Jpn Pharmacol Ther 2004 32(s2) s121
【Discussion 4～5】
Jpn Pharmacol Ther 2004 32(s2) s127
T. Oyama, et al．
Jpn Pharmacol Ther 2004 32(s2) s129
The association of MMP-1, 3 and-9 genotypes with the prognosis of HCV-related hepatocellular carcinoma patients
K. Okamoto, et al．
Jpn Pharmacol Ther 2004 32(s2) s137
Effects of angiotensin II on the expression of MCP-1 in hepatic stellate cell line LI90
K. Kanno, et al．
Jpn Pharmacol Ther 2004 32(s2) s143
【Discussion 7～9】
Jpn Pharmacol Ther 2004 32(s2) s147
Rho regulates hepatic sinusoidal endothelial fenestral actin cytoskeleton
H. Yokomori, et al．
Jpn Pharmacol Ther 2004 32(s2) s149
Endogenous prostaglandins plays a role in concanavalin A-induced liver injury in mice
S. Okamoto, et al．
Jpn Pharmacol Ther 2004 32(s2) s151
Immune tolerance on the liver injury is induced by repeated intravenous injection with concanavalin A in mice
Y. Tamaki, et al．
Jpn Pharmacol Ther 2004 32(s2) s155
Nitric Oxide, induced in the rat liver, improves the glutathion depletion of acetaminophen-caused hepatic injury
T. Asama, et al．
Jpn Pharmacol Ther 2004 32(s2) s161
【Discussion 11～13】
Jpn Pharmacol Ther 2004 32(s2) s165
Urtra fast laser activated photodynamic therapy for neovascularization
K. Awazu, et al．
Jpn Pharmacol Ther 2004 32(s2) s167
Prostaglandin E1 ameliorates hyperbilirubinemia with liver failure
S. Nishimura, et al．
Jpn Pharmacol Ther 2004 32(s2) s173
Bilirubin UDP-glucuronosyltransferase（UGT1A1）polymorphism（G71R） and β-estratiol glucuronidation
Y. Maruo, et al．
Jpn Pharmacol Ther 2004 32(s2) s179
Novel UDP-glucuronosyltransferase（UGT1A3）polymorphisms with varying activity
M. Iwai, et al．
Jpn Pharmacol Ther 2004 32(s2) s183
【Discussion 14～17】
Jpn Pharmacol Ther 2004 32(s2) s189
The mechanism of a clinically relevant drug-drug interaction between cerivastatin and gemfibrozil
Y. Shitara, et al．
Jpn Pharmacol Ther 2004 32(s2) s193
The involvement of OATP2 and OATP8 transporters in the hepatic uptake of fexofenadine
M. Shimizu, et al．
Jpn Pharmacol Ther 2004 32(s2) s201
Role of liver－specific organic anion transporter－2 in cancer cell lines
H. Oshio, et al．
Jpn Pharmacol Ther 2004 32(s2) s205
【Discussion 18～20】
Jpn Pharmacol Ther 2004 32(s2) s207
Effect of colchicine on the maximum biliary excretion of organic anions and cations
M. Takayanagi, et al．
Jpn Pharmacol Ther 2004 32(s2) s211
Biliary excretion mechanism of fexofenadine, a H1 receptor antagonist
H. Tahara, et al．
Jpn Pharmacol Ther 2004 32(s2) s213
Effect of deletion or point mutation on the polarized expression of human BCRP/ABCG2
T. Takada, et al．
Jpn Pharmacol Ther 2004 32(s2) s219
Functional characterization of MRP4
H. Kusuhara, et al．
Jpn Pharmacol Ther 2004 32(s2) s223
【Discussion 21～24】
Jpn Pharmacol Ther 2004 32(s2) s229
Investigation of the contribution of transporters expressed in human canalicular membrane to biliary excretion using double-transfected MDCK II cell lines
S. Matsushima, et al．
Jpn Pharmacol Ther 2004 32(s2) s233
Construction of the in vivo evaluation system of human MRP2 using EHBR
M. Hirouchi, et al．
Jpn Pharmacol Ther 2004 32(s2) s239
Suppression of mouse Mrp2 gene in vitro using RNA interference（RNAi）T.
Watanabe, et al．
Jpn Pharmacol Ther 2004 32(s2) s243
Mrp2 is involved in benzylpenicillin-induced choleresis
K. Ito, et al．
Jpn Pharmacol Ther 2004 32(s2) s247
【Discussion 25～28】
Jpn Pharmacol Ther 2004 32(s2) s253
Closing Remarks
Y. Sugiyama
Jpn Pharmacol Ther 2004 32(s2) s257